{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:46:24Z","timestamp":1792320384115,"version":"4.4.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>We presented a case of subtherapeutic linezolid concentration in a patient with bullous pemphigoid characterized by large area skin anabrosis complicated by methicillin-resistant <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> infections.<\/jats:p>","DOI":"10.1097\/ftd.0000000000000758","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T22:59:09Z","timestamp":1585263549000},"page":"515-517","source":"Crossref","is-referenced-by-count":3,"title":["Subtherapeutic Linezolid Concentration in a Patient With Bullous Pemphigoid Complicated by Methicillin-Resistant Staphylococcus aureus Infection: A Case Study"],"prefix":"10.1097","volume":"42","author":[{"given":"Congqin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, Fujian, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Boston Medical Center, Boston, Massachusetts ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiration and Critical Care Disease, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China;"},{"name":"Institute of Respiratory Diseases, School of Medicine, Shanghai Jiaotong University, Shanghai, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines y the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000445194","article-title":"Decreased linezolid serum concentrations in three critically ill patients: clinical case studies of a potential drug interaction between linezolid and rifampicin","volume":"98","author":"Blassmann","year":"2016","journal-title":"Pharmacology"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/cc13984","article-title":"Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study","volume":"18","author":"Zoller","year":"2014","journal-title":"Crit Care"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00228-015-1922-z","article-title":"Linezolid underexposure in a patient co-treated with venlafaxine","volume":"71","author":"Cojutti","year":"2015","journal-title":"Eur J Clin Pharmacol."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FTD.0000000000000069","article-title":"Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: a case report","volume":"36","author":"Pea","year":"2014","journal-title":"Ther Drug Monit."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1128\/AAC.00177-10","article-title":"Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis","volume":"54","author":"Pea","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40268-015-0117-5","article-title":"Applicability of a single time point strategy for the prediction of area under the concentration curve of linezolid in patients: superiority of ctrough- over cmax-derived linear regression models","volume":"16","author":"Srinivas","year":"2016","journal-title":"Drugs R D"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/17425255.2016.1166204","article-title":"Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones","volume":"12","author":"Cattaneo","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bcpt.12797","article-title":"A 10-year experience of therapeutic drug monitoring (TDM) of linezolid in a hospital-wide population of patients receiving conventional dosing: is there enough evidence for suggesting TDM in the majority of patients?","volume":"121","author":"Pea","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/jac\/dkv238","article-title":"Pharmacokinetics of high dosage of linezolid in two morbidly obese patients","volume":"70","author":"Corcione","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/AAC.48.1.281-284.2004","article-title":"Linezolid pharmacokinetics in adult patients with cystic fibrosis","volume":"48","author":"Bosso","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ppul.20966","article-title":"Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis","volume":"44","author":"Santos","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40780-018-0123-1","article-title":"Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies","volume":"4","author":"Hashimoto","year":"2018","journal-title":"J Pharm Health Care Sci."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/dkn541","article-title":"Pharmacokinetic evaluation of linezolid in patients with major thermal injuries","volume":"63","author":"Lovering","year":"2009","journal-title":"J Antimicrob Chemother."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:25:02Z","timestamp":1692051902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000758","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}